Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 369

1.

Role of Post-Acute Care on Hospital Readmission After High-Risk Surgery.

Lee AJ, Liu X, Borza T, Qin Y, Li BY, Urish KL, Kirk PS, Gilbert S, Hollenbeck BK, Helm JE, Lavieri MS, Skolarus TA, Jacobs BL.

J Surg Res. 2019 Feb;234:116-122. doi: 10.1016/j.jss.2018.08.053. Epub 2018 Oct 6.

PMID:
30527462
2.

Small cell bladder cancer: should we consider prophylactic cranial irradiation?

Morgan TN, Turner RM II, Baptiste J, Lyon TD, Maranchie JK, Hrebinko RL, Davies BJ, Gingrich JR, Jacobs BL.

Int Braz J Urol. 2018 Oct 30;44. doi: 10.1590/S1677-5538.IBJU.2018.0242. [Epub ahead of print]

PMID:
30521161
3.

The role of raptor in the mechanical load-induced regulation of mTOR signaling, protein synthesis, and skeletal muscle hypertrophy.

You JS, McNally RM, Jacobs BL, Privett RE, Gundermann DM, Lin KH, Steinert ND, Goodman CA, Hornberger TA.

FASEB J. 2018 Dec 3:fj201801653RR. doi: 10.1096/fj.201801653RR. [Epub ahead of print]

PMID:
30509128
4.

Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.

Asbach B, Kibler KV, Köstler J, Perdiguero B, Yates NL, Stanfield-Oakley S, Tomaras GD, Kao SF, Foulds KE, Roederer M, Seaman MS, Montefiori DC, Parks R, Ferrari G, Forthal DN, Phogat S, Tartaglia J, Barnett SW, Self SG, Gottardo R, Cristillo AD, Weiss DE, Galmin L, Ding S, Heeney JL, Esteban M, Jacobs BL, Pantaleo G, Wagner R.

J Virol. 2019 Jan 17;93(3). pii: e01529-18. doi: 10.1128/JVI.01529-18. Print 2019 Feb 1.

PMID:
30429343
5.

Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.

Kibler KV, Asbach B, Perdiguero B, García-Arriaza J, Yates NL, Parks R, Stanfield-Oakley S, Ferrari G, Montefiori DC, Tomaras GD, Roederer M, Foulds KE, Forthal DN, Seaman MS, Self S, Gottardo R, Phogat S, Tartaglia J, Barnett S, Cristillo AD, Weiss D, Galmin L, Ding S, Heeney JL, Esteban M, Wagner R, Pantaleo G, Jacobs BL.

J Virol. 2019 Jan 17;93(3). pii: e01513-18. doi: 10.1128/JVI.01513-18. Print 2019 Feb 1.

PMID:
30429340
6.

Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis.

Hugar LA, Yabes JG, Turner RM 2nd, Fam MM, Appleman LJ, Davies BJ, Jacobs BL.

Urology. 2018 Nov 10. pii: S0090-4295(18)31136-1. doi: 10.1016/j.urology.2018.11.001. [Epub ahead of print]

PMID:
30423302
7.

Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas.

Lee AJ, Bandari J, Macleod LC, Davies BJ, Jacobs BL.

J Gen Intern Med. 2018 Nov 6. doi: 10.1007/s11606-018-4700-7. [Epub ahead of print] No abstract available.

PMID:
30402818
8.

Extreme Price Variation for Generic Benign Prostatic Hyperplasia Medications.

Theisen KM, Park SY, Jeong K, Macleod LC, Bandari J, Ayyash O, Odisho AY, Jacobs BL, Davies BJ.

Urology. 2018 Oct 23. pii: S0090-4295(18)31106-3. doi: 10.1016/j.urology.2018.10.020. [Epub ahead of print]

PMID:
30359708
9.

Excessive Opioid Prescribing After Major Urologic Procedures.

Theisen KM, Myrga JM, Hale N, Cochran G, Sewall C, Macleod LC, Jacobs BL, Davies BJ.

Urology. 2019 Jan;123:101-107. doi: 10.1016/j.urology.2018.06.057. Epub 2018 Aug 24.

PMID:
30149041
10.

Effect of multimodal analgesia with paravertebral blocks on biochemical recurrence in men undergoing open radical prostatectomy.

Macleod LC, Turner RM 2nd, Lopa S, Hugar LA, Davies BJ, Ben-David B, Chelly JE, Jacobs BL, Nelson JB.

Urol Oncol. 2018 Aug;36(8):364.e9-364.e14. doi: 10.1016/j.urolonc.2018.05.016. Epub 2018 Jun 7.

PMID:
29887239
11.

Predictors and Cost of Readmission in Total Knee Arthroplasty.

Urish KL, Qin Y, Li BY, Borza T, Sessine M, Kirk P, Hollenbeck BK, Helm JE, Lavieri MS, Skolarus TA, Jacobs BL.

J Arthroplasty. 2018 Sep;33(9):2759-2763. doi: 10.1016/j.arth.2018.04.008. Epub 2018 Apr 17.

PMID:
29753618
12.

The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients.

Lee AJ, Yabes JG, Hale N, Hrebinko RL, Gingrich JR, Maranchie JK, Fam MM, Turner I I RM, Davies BJ, Ben-David B, Jacobs BL.

Can J Urol. 2018 Apr;25(2):9255-9261..

PMID:
29680003
13.

Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.

Singh KB, Kim SH, Hahm ER, Pore SK, Jacobs BL, Singh SV.

Carcinogenesis. 2018 May 28;39(6):826-837. doi: 10.1093/carcin/bgy051.

PMID:
29668854
14.

Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer.

Luckenbaugh AN, Hollenbeck BK, Kaufman SR, Yan P, Herrel LA, Skolarus TA, Norton EC, Schroeck FR, Jacobs BL, Miller DC, Hollingsworth JM, Shahinian VB, Borza T.

Urology. 2018 Jun;116:68-75. doi: 10.1016/j.urology.2018.01.056. Epub 2018 Apr 6.

PMID:
29630957
15.

Association Between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery.

Borza T, Oerline MK, Skolarus TA, Norton EC, Dimick JB, Jacobs BL, Herrel LA, Ellimoottil C, Hollingsworth JM, Ryan AM, Miller DC, Shahinian VB, Hollenbeck BK.

Ann Surg. 2018 Mar 19. doi: 10.1097/SLA.0000000000002737. [Epub ahead of print]

PMID:
29557880
16.

Challenges in the Analysis of Outcomes for Surgical Compared to Radiotherapy Treatment of Prostate Cancer.

Glaser SM, Kalash R, Bongiorni DR, Roberts MS, Balasubramani GK, Jacobs BL, Beriwal S, Heron DE, Greenberger JS.

In Vivo. 2018 Jan-Feb;32(1):113-120.

17.

Evidence-Based Reporting: A Method to Optimize Prostate MRI Communications With Referring Physicians.

Magnetta MJ, Donovan AL, Jacobs BL, Davies BJ, Furlan A.

AJR Am J Roentgenol. 2018 Jan;210(1):108-112. doi: 10.2214/AJR.17.18260. Epub 2017 Nov 1.

PMID:
29091009
18.

Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.

Koehler H, Cotsmire S, Langland J, Kibler KV, Kalman D, Upton JW, Mocarski ES, Jacobs BL.

Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11506-11511. doi: 10.1073/pnas.1700999114. Epub 2017 Oct 9.

19.

Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care.

Borza T, Kaufman SR, Yan P, Herrel LA, Luckenbaugh AN, Miller DC, Skolarus TA, Jacobs BL, Hollingsworth JM, Norton EC, Shahinian VB, Hollenbeck BK.

Cancer. 2018 Feb 1;124(3):563-570. doi: 10.1002/cncr.31081. Epub 2017 Oct 20.

PMID:
29053177
20.

The Comparative Effectiveness of Treatments for Ureteropelvic Junction Obstruction.

Jacobs BL, Lai JC, Seelam R, Hanley JM, Wolf JS Jr, Hollenbeck BK, Hollingsworth JM, Dick AW, Setodji CM, Saigal CS; Urologic Diseases in America Project.

Urology. 2018 Jan;111:72-77. doi: 10.1016/j.urology.2017.09.002. Epub 2017 Sep 21.

21.

Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system.

Huynh TP, Jancovich JK, Tripuraneni L, Heck MC, Langland JO, Jacobs BL.

Virology. 2017 Nov;511:290-299. doi: 10.1016/j.virol.2017.08.012. Epub 2017 Sep 14.

22.

Preoperative immunonutrition prior to radical cystectomy: a pilot study.

Lyon TD, Turner I I RM, McBride D, Wang L, Gingrich JR, Hrebinko RL, Jacobs BL, Davies BJ, Tarin TV.

Can J Urol. 2017 Aug;24(4):8895-8901.

PMID:
28832307
23.

Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.

Hollenbeck BK, Kaufman SR, Yan P, Herrel LA, Borza T, Schroeck FR, Jacobs BL, Skolarus TA, Shahinian VB.

Eur Urol. 2018 Apr;73(4):491-498. doi: 10.1016/j.eururo.2017.08.001. Epub 2017 Aug 18.

PMID:
28823605
24.

Editorial Comment: Industry Payments to Urologists in 2014: an Analysis of the Open Payments Program.

Bandari J, Jacobs BL.

Urol Pract. 2017 Jul;4(4):347. No abstract available.

25.

The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission Interval.

Krishnan N, Li B, Jacobs BL, Ambani SN, Borza T, He C, Hollenbeck BK, Morgan T, Hafez KS, Weizer AZ, Montgomery JS, Lee CT, Lesse O, Lavieri MS, Helm JE, Skolarus TA.

Eur Urol Focus. 2018 Sep;4(5):711-717. doi: 10.1016/j.euf.2016.07.004. Epub 2016 Aug 4.

PMID:
28753778
26.

The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.

Bandari J, Ayyash OM, Turner RM 2nd, Jacobs BL, Davies BJ.

Cancer. 2017 Nov 15;123(22):4356-4362. doi: 10.1002/cncr.30914. Epub 2017 Jul 27.

27.

Variation in readmission expenditures after high-risk surgery.

Jacobs BL, He C, Li BY, Helfand A, Krishnan N, Borza T, Ghaferi AA, Hollenbeck BK, Helm JE, Lavieri MS, Skolarus TA.

J Surg Res. 2017 Jun 1;213:60-68. doi: 10.1016/j.jss.2017.02.017. Epub 2017 Feb 23.

28.

A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.

Meador LR, Kessans SA, Kilbourne J, Kibler KV, Pantaleo G, Roderiguez ME, Blattman JN, Jacobs BL, Mor TS.

Virology. 2017 Jul;507:242-256. doi: 10.1016/j.virol.2017.04.008. Epub 2017 Apr 28.

29.

Comparative effectiveness in urology: a state of the art review utilizing a systematic approach.

Bandari J, Wessel CB, Jacobs BL.

Curr Opin Urol. 2017 Jul;27(4):380-394. doi: 10.1097/MOU.0000000000000405. Review.

PMID:
28426464
30.

Epidemiology of the Small Renal Mass and the Treatment Disconnect Phenomenon.

Turner RM 2nd, Morgan TM, Jacobs BL.

Urol Clin North Am. 2017 May;44(2):147-154. doi: 10.1016/j.ucl.2016.12.001. Epub 2017 Mar 14. Review.

31.

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.

Schroeck FR, Jacobs BL, Bhayani SB, Nguyen PL, Penson D, Hu J.

Eur Urol. 2017 Nov;72(5):712-735. doi: 10.1016/j.eururo.2017.03.028. Epub 2017 Mar 31. Review.

32.

The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.

Jacobs BL, Yabes JG, Lopa SH, Heron DE, Chang CH, Schroeck FR, Bekelman JE, Kahn JM, Nelson JB, Barnato AE.

Cancer. 2017 Aug 1;123(15):2945-2954. doi: 10.1002/cncr.30574. Epub 2017 Mar 16.

33.

Identification of mechanically regulated phosphorylation sites on tuberin (TSC2) that control mechanistic target of rapamycin (mTOR) signaling.

Jacobs BL, McNally RM, Kim KJ, Blanco R, Privett RE, You JS, Hornberger TA.

J Biol Chem. 2017 Apr 28;292(17):6987-6997. doi: 10.1074/jbc.M117.777805. Epub 2017 Mar 13.

34.

No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care.

Borza T, Jacobs BL, Montgomery JS, Weizer AZ, Morgan TM, Hafez KS, Lee CT, Li BY, Min HS, He C, Gilbert SM, Helm JE, Lavieri MS, Hollenbeck BK, Skolarus TA.

Urology. 2017 Jun;104:77-83. doi: 10.1016/j.urology.2017.01.042. Epub 2017 Mar 4.

35.

Variations in Preoperative Use of Bone Scan Among Medicare Beneficiaries Undergoing Radical Cystectomy.

Turner RM 2nd, Yabes JG, Davies BJ, Heron DE, Jacobs BL.

Urology. 2017 May;103:84-90. doi: 10.1016/j.urology.2017.02.028. Epub 2017 Feb 24.

36.

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.

García-Arriaza J, Perdiguero B, Heeney JL, Seaman MS, Montefiori DC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Self SG, Borate B, Gottardo R, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo AD, Weiss DE, Lee C, Kibler KV, Jacobs BL, Wagner R, Ding S, Pantaleo G, Esteban M.

J Virol. 2017 Apr 13;91(9). pii: e02182-16. doi: 10.1128/JVI.02182-16. Print 2017 May 1.

37.

The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab.

Bandari J, Turner RM 2nd, Jacobs BL, Canes D, Moinzadeh A, Davies BJ.

Urol Pract. 2017 Jan;4(1):14-20. doi: 10.1016/j.urpr.2016.03.007.

38.

Prognostic implications of immediate PSA response to early salvage radiotherapy.

Turner I I RM, Yabes JG, Woldemichael E, Deutsch MM, Smith RP, Werner RS, Jacobs BL, Nelson JB.

Can J Urol. 2016 Dec;23(6):8568-8575.

PMID:
27995853
39.

Variation in the Use of Open Pyeloplasty, Minimally Invasive Pyeloplasty, and Endopyelotomy for the Treatment of Ureteropelvic Junction Obstruction in Adults.

Jacobs BL, Lai JC, Seelam R, Hanley JM, Wolf JS Jr, Hollenbeck BK, Hollingsworth JM, Dick AW, Setodji CM, Saigal CS.

J Endourol. 2017 Feb;31(2):210-215. doi: 10.1089/end.2016.0688. Epub 2017 Jan 5.

40.

Cost Analysis of Treatments for Ureteropelvic Junction Obstruction.

Jacobs BL, Seelam R, Lai JC, Hanley JM, Wolf JS Jr, Hollenbeck BK, Hollingsworth JM, Dick AW, Setodji CM, Saigal CS.

J Endourol. 2017 Feb;31(2):204-209. doi: 10.1089/end.2016.0722. Epub 2017 Jan 5.

41.

Biopsy Perineural Invasion in Prostate Cancer Patients Who Are Candidates for Active Surveillance by Strict and Expanded Criteria.

Turner RM 2nd, Yecies TS, Yabes JG, Ristau BT, Woldemichael E, Davies BJ, Jacobs BL, Nelson JB.

Urology. 2017 Apr;102:173-177. doi: 10.1016/j.urology.2016.11.011. Epub 2016 Nov 15.

42.

Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?

Ambani SN, Morgan TM, Montgomery JS, Gadzinski AJ, Jacobs BL, Hawken S, Krishnan N, Caoili EM, Ellis JH, Kunju LP, Hafez KS, Miller DC, Palapattu GS, Weizer AZ, Wolf JS Jr.

Urology. 2016 Dec;98:88-96. doi: 10.1016/j.urology.2016.04.067. Epub 2016 Jul 19.

PMID:
27450936
43.

Urology Payments from Industry in the Sunshine Act.

Bandari J, Turner RM 2nd, Jacobs BL, Davies BJ.

Urol Pract. 2016 Sep;3(5):332-337.

44.

Molecular Cytogenetics as a Diagnostic Aid for Primary Liposarcoma of the Spermatic Cord.

Hugar LA, Quiroga-Garza GM, Davies BJ, Hrebinko RL, Tran T, Jacobs BL.

Clin Genitourin Cancer. 2017 Feb;15(1):e83-e89. doi: 10.1016/j.clgc.2016.08.008. Epub 2016 Aug 10. Review. No abstract available.

PMID:
27666164
45.

Payments to Pediatricians in the Sunshine Act.

Karas DJ, Bandari J, Browning DN, Jacobs BL, Davies BJ.

Clin Pediatr (Phila). 2017 Jul;56(8):723-728. doi: 10.1177/0009922816670981. Epub 2016 Sep 23.

PMID:
27663966
46.

Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading.

Lyon TD, Turner RM 2nd, Yabes JG, Woldemichael E, Davies BJ, Jacobs BL, Nelson JB.

Urology. 2016 Nov;97:153-159. doi: 10.1016/j.urology.2016.08.004. Epub 2016 Aug 8.

PMID:
27516122
47.

Local coverage determination policy and the use of stereotactic body radiation therapy for prostate cancer.

Jacobs BL, Sunderland R, Yabes J, Nelson JB, Barnato AE, Bekelman JE.

Urol Pract. 2015 Nov;2(6):304-311.

48.

Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus.

Arndt WD, White SD, Johnson BP, Huynh T, Liao J, Harrington H, Cotsmire S, Kibler KV, Langland J, Jacobs BL.

Virology. 2016 Oct;497:125-135. doi: 10.1016/j.virol.2016.07.016. Epub 2016 Jul 26.

49.

Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population.

Jacobs BL, Lopa SH, Yabes JG, Nelson JB, Barnato AE, Degenholtz HB.

Cancer. 2016 Oct 15;122(20):3199-3206. doi: 10.1002/cncr.30184. Epub 2016 Jul 5.

50.

Panniculectomy and Cystectomy: An Approach to the Morbidly Obese Patient.

Hugar LA, Turner RM, Gusenoff JA, Correa AF, Jacobs BL, Davies BJ.

Case Rep Urol. 2016;2016:6980843. doi: 10.1155/2016/6980843. Epub 2016 Apr 18.

Supplemental Content

Loading ...
Support Center